Pliant Therapeutics Operating Income

Pliant Therapeutics (PLRX) currently reports a operating income of $-120M as of March 2026. That compares with $-230M in the prior-year period — up 48.7% year over year. Use the charts on this page to explore Pliant Therapeutics's operating income history and peer comparisons.

Pliant Therapeutics's operating income increased from $-230M to $-120M — a 48.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pliant Therapeutics reported $-120M in operating income as of March 2026. That compares with $-230M in the prior-year period — up 48.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pliant Therapeutics, and consider following PLRX for alerts when major investors trade the stock.

Pliant Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLRX with unrelated industries.